Global Long-acting Reversible Contraceptives (LARCs) Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Long-acting Reversible Contraceptives (LARCs) market size was valued at US$ million in 2023. With growing demand in downstream market, the Long-acting Reversible Contraceptives (LARCs) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Long-acting Reversible Contraceptives (LARCs) market. Long-acting Reversible Contraceptives (LARCs) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Long-acting Reversible Contraceptives (LARCs). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Long-acting Reversible Contraceptives (LARCs) market.
Key Features:
The report on Long-acting Reversible Contraceptives (LARCs) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Long-acting Reversible Contraceptives (LARCs) market. It may include historical data, market segmentation by Type (e.g., Hormonal Intrauterine Devices, Copper Intrauterine Devices), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Long-acting Reversible Contraceptives (LARCs) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Long-acting Reversible Contraceptives (LARCs) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Long-acting Reversible Contraceptives (LARCs) industry. This include advancements in Long-acting Reversible Contraceptives (LARCs) technology, Long-acting Reversible Contraceptives (LARCs) new entrants, Long-acting Reversible Contraceptives (LARCs) new investment, and other innovations that are shaping the future of Long-acting Reversible Contraceptives (LARCs).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Long-acting Reversible Contraceptives (LARCs) market. It includes factors influencing customer ' purchasing decisions, preferences for Long-acting Reversible Contraceptives (LARCs) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Long-acting Reversible Contraceptives (LARCs) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Long-acting Reversible Contraceptives (LARCs) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Long-acting Reversible Contraceptives (LARCs) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Long-acting Reversible Contraceptives (LARCs) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Long-acting Reversible Contraceptives (LARCs) market.
Market Segmentation:
Long-acting Reversible Contraceptives (LARCs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Long-acting Reversible Contraceptives (LARCs) market?
What factors are driving Long-acting Reversible Contraceptives (LARCs) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-acting Reversible Contraceptives (LARCs) market opportunities vary by end market size?
How does Long-acting Reversible Contraceptives (LARCs) break out type, application?
According to our LPI (LP Information) latest study, the global Long-acting Reversible Contraceptives (LARCs) market size was valued at US$ million in 2023. With growing demand in downstream market, the Long-acting Reversible Contraceptives (LARCs) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Long-acting Reversible Contraceptives (LARCs) market. Long-acting Reversible Contraceptives (LARCs) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Long-acting Reversible Contraceptives (LARCs). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Long-acting Reversible Contraceptives (LARCs) market.
Key Features:
The report on Long-acting Reversible Contraceptives (LARCs) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Long-acting Reversible Contraceptives (LARCs) market. It may include historical data, market segmentation by Type (e.g., Hormonal Intrauterine Devices, Copper Intrauterine Devices), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Long-acting Reversible Contraceptives (LARCs) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Long-acting Reversible Contraceptives (LARCs) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Long-acting Reversible Contraceptives (LARCs) industry. This include advancements in Long-acting Reversible Contraceptives (LARCs) technology, Long-acting Reversible Contraceptives (LARCs) new entrants, Long-acting Reversible Contraceptives (LARCs) new investment, and other innovations that are shaping the future of Long-acting Reversible Contraceptives (LARCs).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Long-acting Reversible Contraceptives (LARCs) market. It includes factors influencing customer ' purchasing decisions, preferences for Long-acting Reversible Contraceptives (LARCs) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Long-acting Reversible Contraceptives (LARCs) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Long-acting Reversible Contraceptives (LARCs) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Long-acting Reversible Contraceptives (LARCs) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Long-acting Reversible Contraceptives (LARCs) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Long-acting Reversible Contraceptives (LARCs) market.
Market Segmentation:
Long-acting Reversible Contraceptives (LARCs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Hormonal Intrauterine Devices
- Copper Intrauterine Devices
- Contraceptive Implants
- Others
- Age 20-24
- Age 25-34
- Age 35-44
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Merck
- Cooper Companies
- AbbVie Allergan
- Yantai JiShengYaoXie
- H & J Medical
- HRA Pharma
- Pregna
- ASPIVIX
- Shanghai Dahua Pharmaceuticals
- Williams Medical Supplies
- Laboratoire 7 MED
- Durbin
- Laboratoire CCD
- Prosan
- OCON
What is the 10-year outlook for the global Long-acting Reversible Contraceptives (LARCs) market?
What factors are driving Long-acting Reversible Contraceptives (LARCs) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-acting Reversible Contraceptives (LARCs) market opportunities vary by end market size?
How does Long-acting Reversible Contraceptives (LARCs) break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting Reversible Contraceptives (LARCs) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Long-acting Reversible Contraceptives (LARCs) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Long-acting Reversible Contraceptives (LARCs) by Country/Region, 2019, 2023 & 2030
2.2 Long-acting Reversible Contraceptives (LARCs) Segment by Type
2.2.1 Hormonal Intrauterine Devices
2.2.2 Copper Intrauterine Devices
2.2.3 Contraceptive Implants
2.2.4 Others
2.3 Long-acting Reversible Contraceptives (LARCs) Sales by Type
2.3.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2019-2024)
2.3.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Type (2019-2024)
2.4 Long-acting Reversible Contraceptives (LARCs) Segment by Application
2.4.1 Age 20-24
2.4.2 Age 25-34
2.4.3 Age 35-44
2.4.4 Others
2.5 Long-acting Reversible Contraceptives (LARCs) Sales by Application
2.5.1 Global Long-acting Reversible Contraceptives (LARCs) Sale Market Share by Application (2019-2024)
2.5.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Application (2019-2024)
3 GLOBAL LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARCS) BY COMPANY
3.1 Global Long-acting Reversible Contraceptives (LARCs) Breakdown Data by Company
3.1.1 Global Long-acting Reversible Contraceptives (LARCs) Annual Sales by Company (2019-2024)
3.1.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Company (2019-2024)
3.2 Global Long-acting Reversible Contraceptives (LARCs) Annual Revenue by Company (2019-2024)
3.2.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Company (2019-2024)
3.2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Company (2019-2024)
3.3 Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Company
3.4 Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Product Location Distribution
3.4.2 Players Long-acting Reversible Contraceptives (LARCs) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARCS) BY GEOGRAPHIC REGION
4.1 World Historic Long-acting Reversible Contraceptives (LARCs) Market Size by Geographic Region (2019-2024)
4.1.1 Global Long-acting Reversible Contraceptives (LARCs) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Long-acting Reversible Contraceptives (LARCs) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Long-acting Reversible Contraceptives (LARCs) Market Size by Country/Region (2019-2024)
4.2.1 Global Long-acting Reversible Contraceptives (LARCs) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Long-acting Reversible Contraceptives (LARCs) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Long-acting Reversible Contraceptives (LARCs) Sales Growth
4.4 APAC Long-acting Reversible Contraceptives (LARCs) Sales Growth
4.5 Europe Long-acting Reversible Contraceptives (LARCs) Sales Growth
4.6 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Growth
5 AMERICAS
5.1 Americas Long-acting Reversible Contraceptives (LARCs) Sales by Country
5.1.1 Americas Long-acting Reversible Contraceptives (LARCs) Sales by Country (2019-2024)
5.1.2 Americas Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2019-2024)
5.2 Americas Long-acting Reversible Contraceptives (LARCs) Sales by Type
5.3 Americas Long-acting Reversible Contraceptives (LARCs) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting Reversible Contraceptives (LARCs) Sales by Region
6.1.1 APAC Long-acting Reversible Contraceptives (LARCs) Sales by Region (2019-2024)
6.1.2 APAC Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2019-2024)
6.2 APAC Long-acting Reversible Contraceptives (LARCs) Sales by Type
6.3 APAC Long-acting Reversible Contraceptives (LARCs) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting Reversible Contraceptives (LARCs) by Country
7.1.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2019-2024)
7.1.2 Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2019-2024)
7.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type
7.3 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) by Country
8.1.1 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2019-2024)
8.2 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type
8.3 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting Reversible Contraceptives (LARCs)
10.3 Manufacturing Process Analysis of Long-acting Reversible Contraceptives (LARCs)
10.4 Industry Chain Structure of Long-acting Reversible Contraceptives (LARCs)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting Reversible Contraceptives (LARCs) Distributors
11.3 Long-acting Reversible Contraceptives (LARCs) Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARCS) BY GEOGRAPHIC REGION
12.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size Forecast by Region
12.1.1 Global Long-acting Reversible Contraceptives (LARCs) Forecast by Region (2025-2030)
12.1.2 Global Long-acting Reversible Contraceptives (LARCs) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Long-acting Reversible Contraceptives (LARCs) Forecast by Type
12.7 Global Long-acting Reversible Contraceptives (LARCs) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Cooper Companies
13.3.1 Cooper Companies Company Information
13.3.2 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Cooper Companies Main Business Overview
13.3.5 Cooper Companies Latest Developments
13.4 AbbVie Allergan
13.4.1 AbbVie Allergan Company Information
13.4.2 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 AbbVie Allergan Main Business Overview
13.4.5 AbbVie Allergan Latest Developments
13.5 Yantai JiShengYaoXie
13.5.1 Yantai JiShengYaoXie Company Information
13.5.2 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Yantai JiShengYaoXie Main Business Overview
13.5.5 Yantai JiShengYaoXie Latest Developments
13.6 H & J Medical
13.6.1 H & J Medical Company Information
13.6.2 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 H & J Medical Main Business Overview
13.6.5 H & J Medical Latest Developments
13.7 HRA Pharma
13.7.1 HRA Pharma Company Information
13.7.2 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.7.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 HRA Pharma Main Business Overview
13.7.5 HRA Pharma Latest Developments
13.8 Pregna
13.8.1 Pregna Company Information
13.8.2 Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pregna Main Business Overview
13.8.5 Pregna Latest Developments
13.9 ASPIVIX
13.9.1 ASPIVIX Company Information
13.9.2 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 ASPIVIX Main Business Overview
13.9.5 ASPIVIX Latest Developments
13.10 Shanghai Dahua Pharmaceuticals
13.10.1 Shanghai Dahua Pharmaceuticals Company Information
13.10.2 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Shanghai Dahua Pharmaceuticals Main Business Overview
13.10.5 Shanghai Dahua Pharmaceuticals Latest Developments
13.11 Williams Medical Supplies
13.11.1 Williams Medical Supplies Company Information
13.11.2 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Williams Medical Supplies Main Business Overview
13.11.5 Williams Medical Supplies Latest Developments
13.12 Laboratoire 7 MED
13.12.1 Laboratoire 7 MED Company Information
13.12.2 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Laboratoire 7 MED Main Business Overview
13.12.5 Laboratoire 7 MED Latest Developments
13.13 Durbin
13.13.1 Durbin Company Information
13.13.2 Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Durbin Main Business Overview
13.13.5 Durbin Latest Developments
13.14 Laboratoire CCD
13.14.1 Laboratoire CCD Company Information
13.14.2 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Laboratoire CCD Main Business Overview
13.14.5 Laboratoire CCD Latest Developments
13.15 Prosan
13.15.1 Prosan Company Information
13.15.2 Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Prosan Main Business Overview
13.15.5 Prosan Latest Developments
13.16 OCON
13.16.1 OCON Company Information
13.16.2 OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 OCON Main Business Overview
13.16.5 OCON Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting Reversible Contraceptives (LARCs) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Long-acting Reversible Contraceptives (LARCs) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Long-acting Reversible Contraceptives (LARCs) by Country/Region, 2019, 2023 & 2030
2.2 Long-acting Reversible Contraceptives (LARCs) Segment by Type
2.2.1 Hormonal Intrauterine Devices
2.2.2 Copper Intrauterine Devices
2.2.3 Contraceptive Implants
2.2.4 Others
2.3 Long-acting Reversible Contraceptives (LARCs) Sales by Type
2.3.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2019-2024)
2.3.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Type (2019-2024)
2.4 Long-acting Reversible Contraceptives (LARCs) Segment by Application
2.4.1 Age 20-24
2.4.2 Age 25-34
2.4.3 Age 35-44
2.4.4 Others
2.5 Long-acting Reversible Contraceptives (LARCs) Sales by Application
2.5.1 Global Long-acting Reversible Contraceptives (LARCs) Sale Market Share by Application (2019-2024)
2.5.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Application (2019-2024)
3 GLOBAL LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARCS) BY COMPANY
3.1 Global Long-acting Reversible Contraceptives (LARCs) Breakdown Data by Company
3.1.1 Global Long-acting Reversible Contraceptives (LARCs) Annual Sales by Company (2019-2024)
3.1.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Company (2019-2024)
3.2 Global Long-acting Reversible Contraceptives (LARCs) Annual Revenue by Company (2019-2024)
3.2.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Company (2019-2024)
3.2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Company (2019-2024)
3.3 Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Company
3.4 Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Product Location Distribution
3.4.2 Players Long-acting Reversible Contraceptives (LARCs) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARCS) BY GEOGRAPHIC REGION
4.1 World Historic Long-acting Reversible Contraceptives (LARCs) Market Size by Geographic Region (2019-2024)
4.1.1 Global Long-acting Reversible Contraceptives (LARCs) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Long-acting Reversible Contraceptives (LARCs) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Long-acting Reversible Contraceptives (LARCs) Market Size by Country/Region (2019-2024)
4.2.1 Global Long-acting Reversible Contraceptives (LARCs) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Long-acting Reversible Contraceptives (LARCs) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Long-acting Reversible Contraceptives (LARCs) Sales Growth
4.4 APAC Long-acting Reversible Contraceptives (LARCs) Sales Growth
4.5 Europe Long-acting Reversible Contraceptives (LARCs) Sales Growth
4.6 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Growth
5 AMERICAS
5.1 Americas Long-acting Reversible Contraceptives (LARCs) Sales by Country
5.1.1 Americas Long-acting Reversible Contraceptives (LARCs) Sales by Country (2019-2024)
5.1.2 Americas Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2019-2024)
5.2 Americas Long-acting Reversible Contraceptives (LARCs) Sales by Type
5.3 Americas Long-acting Reversible Contraceptives (LARCs) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting Reversible Contraceptives (LARCs) Sales by Region
6.1.1 APAC Long-acting Reversible Contraceptives (LARCs) Sales by Region (2019-2024)
6.1.2 APAC Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2019-2024)
6.2 APAC Long-acting Reversible Contraceptives (LARCs) Sales by Type
6.3 APAC Long-acting Reversible Contraceptives (LARCs) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting Reversible Contraceptives (LARCs) by Country
7.1.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2019-2024)
7.1.2 Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2019-2024)
7.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type
7.3 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) by Country
8.1.1 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2019-2024)
8.2 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type
8.3 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting Reversible Contraceptives (LARCs)
10.3 Manufacturing Process Analysis of Long-acting Reversible Contraceptives (LARCs)
10.4 Industry Chain Structure of Long-acting Reversible Contraceptives (LARCs)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting Reversible Contraceptives (LARCs) Distributors
11.3 Long-acting Reversible Contraceptives (LARCs) Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING REVERSIBLE CONTRACEPTIVES (LARCS) BY GEOGRAPHIC REGION
12.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size Forecast by Region
12.1.1 Global Long-acting Reversible Contraceptives (LARCs) Forecast by Region (2025-2030)
12.1.2 Global Long-acting Reversible Contraceptives (LARCs) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Long-acting Reversible Contraceptives (LARCs) Forecast by Type
12.7 Global Long-acting Reversible Contraceptives (LARCs) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Cooper Companies
13.3.1 Cooper Companies Company Information
13.3.2 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Cooper Companies Main Business Overview
13.3.5 Cooper Companies Latest Developments
13.4 AbbVie Allergan
13.4.1 AbbVie Allergan Company Information
13.4.2 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 AbbVie Allergan Main Business Overview
13.4.5 AbbVie Allergan Latest Developments
13.5 Yantai JiShengYaoXie
13.5.1 Yantai JiShengYaoXie Company Information
13.5.2 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Yantai JiShengYaoXie Main Business Overview
13.5.5 Yantai JiShengYaoXie Latest Developments
13.6 H & J Medical
13.6.1 H & J Medical Company Information
13.6.2 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 H & J Medical Main Business Overview
13.6.5 H & J Medical Latest Developments
13.7 HRA Pharma
13.7.1 HRA Pharma Company Information
13.7.2 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.7.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 HRA Pharma Main Business Overview
13.7.5 HRA Pharma Latest Developments
13.8 Pregna
13.8.1 Pregna Company Information
13.8.2 Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pregna Main Business Overview
13.8.5 Pregna Latest Developments
13.9 ASPIVIX
13.9.1 ASPIVIX Company Information
13.9.2 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 ASPIVIX Main Business Overview
13.9.5 ASPIVIX Latest Developments
13.10 Shanghai Dahua Pharmaceuticals
13.10.1 Shanghai Dahua Pharmaceuticals Company Information
13.10.2 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Shanghai Dahua Pharmaceuticals Main Business Overview
13.10.5 Shanghai Dahua Pharmaceuticals Latest Developments
13.11 Williams Medical Supplies
13.11.1 Williams Medical Supplies Company Information
13.11.2 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Williams Medical Supplies Main Business Overview
13.11.5 Williams Medical Supplies Latest Developments
13.12 Laboratoire 7 MED
13.12.1 Laboratoire 7 MED Company Information
13.12.2 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Laboratoire 7 MED Main Business Overview
13.12.5 Laboratoire 7 MED Latest Developments
13.13 Durbin
13.13.1 Durbin Company Information
13.13.2 Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Durbin Main Business Overview
13.13.5 Durbin Latest Developments
13.14 Laboratoire CCD
13.14.1 Laboratoire CCD Company Information
13.14.2 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Laboratoire CCD Main Business Overview
13.14.5 Laboratoire CCD Latest Developments
13.15 Prosan
13.15.1 Prosan Company Information
13.15.2 Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Prosan Main Business Overview
13.15.5 Prosan Latest Developments
13.16 OCON
13.16.1 OCON Company Information
13.16.2 OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
13.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 OCON Main Business Overview
13.16.5 OCON Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-acting Reversible Contraceptives (LARCs) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Long-acting Reversible Contraceptives (LARCs) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Hormonal Intrauterine Devices
Table 4. Major Players of Copper Intrauterine Devices
Table 5. Major Players of Contraceptive Implants
Table 6. Major Players of Others
Table 7. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2019-2024) & (K Units)
Table 8. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2019-2024)
Table 9. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2019-2024) & ($ million)
Table 10. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2019-2024)
Table 11. Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2019-2024) & (K Units)
Table 13. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2019-2024)
Table 14. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2019-2024)
Table 15. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2019-2024)
Table 16. Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Long-acting Reversible Contraceptives (LARCs) Sales by Company (2019-2024) & (K Units)
Table 18. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Company (2019-2024)
Table 19. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Company (2019-2024)
Table 21. Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Producing Area Distribution and Sales Area
Table 23. Players Long-acting Reversible Contraceptives (LARCs) Products Offered
Table 24. Long-acting Reversible Contraceptives (LARCs) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Long-acting Reversible Contraceptives (LARCs) Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share Geographic Region (2019-2024)
Table 29. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Long-acting Reversible Contraceptives (LARCs) Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country/Region (2019-2024)
Table 33. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Long-acting Reversible Contraceptives (LARCs) Sales by Country (2019-2024) & (K Units)
Table 36. Americas Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2019-2024)
Table 37. Americas Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2019-2024)
Table 39. Americas Long-acting Reversible Contraceptives (LARCs) Sales by Type (2019-2024) & (K Units)
Table 40. Americas Long-acting Reversible Contraceptives (LARCs) Sales by Application (2019-2024) & (K Units)
Table 41. APAC Long-acting Reversible Contraceptives (LARCs) Sales by Region (2019-2024) & (K Units)
Table 42. APAC Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2019-2024)
Table 43. APAC Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2019-2024)
Table 45. APAC Long-acting Reversible Contraceptives (LARCs) Sales by Type (2019-2024) & (K Units)
Table 46. APAC Long-acting Reversible Contraceptives (LARCs) Sales by Application (2019-2024) & (K Units)
Table 47. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2019-2024) & (K Units)
Table 48. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2019-2024)
Table 49. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2019-2024)
Table 51. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2019-2024) & (K Units)
Table 52. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Long-acting Reversible Contraceptives (LARCs)
Table 60. Key Market Challenges & Risks of Long-acting Reversible Contraceptives (LARCs)
Table 61. Key Industry Trends of Long-acting Reversible Contraceptives (LARCs)
Table 62. Long-acting Reversible Contraceptives (LARCs) Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Long-acting Reversible Contraceptives (LARCs) Distributors List
Table 65. Long-acting Reversible Contraceptives (LARCs) Customer List
Table 66. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Bayer Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 81. Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 82. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bayer Main Business
Table 84. Bayer Latest Developments
Table 85. Merck Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 86. Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 87. Merck Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Merck Main Business
Table 89. Merck Latest Developments
Table 90. Cooper Companies Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 91. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 92. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Cooper Companies Main Business
Table 94. Cooper Companies Latest Developments
Table 95. AbbVie Allergan Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 96. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 97. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. AbbVie Allergan Main Business
Table 99. AbbVie Allergan Latest Developments
Table 100. Yantai JiShengYaoXie Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 101. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 102. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Yantai JiShengYaoXie Main Business
Table 104. Yantai JiShengYaoXie Latest Developments
Table 105. H & J Medical Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 106. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 107. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. H & J Medical Main Business
Table 109. H & J Medical Latest Developments
Table 110. HRA Pharma Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 111. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 112. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. HRA Pharma Main Business
Table 114. HRA Pharma Latest Developments
Table 115. Pregna Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 116. Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 117. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Pregna Main Business
Table 119. Pregna Latest Developments
Table 120. ASPIVIX Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 121. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 122. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. ASPIVIX Main Business
Table 124. ASPIVIX Latest Developments
Table 125. Shanghai Dahua Pharmaceuticals Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 126. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 127. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Shanghai Dahua Pharmaceuticals Main Business
Table 129. Shanghai Dahua Pharmaceuticals Latest Developments
Table 130. Williams Medical Supplies Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 131. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 132. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Williams Medical Supplies Main Business
Table 134. Williams Medical Supplies Latest Developments
Table 135. Laboratoire 7 MED Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 136. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 137. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Laboratoire 7 MED Main Business
Table 139. Laboratoire 7 MED Latest Developments
Table 140. Durbin Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 141. Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 142. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Durbin Main Business
Table 144. Durbin Latest Developments
Table 145. Laboratoire CCD Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 146. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 147. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Laboratoire CCD Main Business
Table 149. Laboratoire CCD Latest Developments
Table 150. Prosan Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 151. Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 152. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Prosan Main Business
Table 154. Prosan Latest Developments
Table 155. OCON Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 156. OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 157. OCON Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. OCON Main Business
Table 159. OCON Latest Developments
Table 1. Long-acting Reversible Contraceptives (LARCs) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Long-acting Reversible Contraceptives (LARCs) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Hormonal Intrauterine Devices
Table 4. Major Players of Copper Intrauterine Devices
Table 5. Major Players of Contraceptive Implants
Table 6. Major Players of Others
Table 7. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2019-2024) & (K Units)
Table 8. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2019-2024)
Table 9. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2019-2024) & ($ million)
Table 10. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2019-2024)
Table 11. Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2019-2024) & (K Units)
Table 13. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2019-2024)
Table 14. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2019-2024)
Table 15. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2019-2024)
Table 16. Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Long-acting Reversible Contraceptives (LARCs) Sales by Company (2019-2024) & (K Units)
Table 18. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Company (2019-2024)
Table 19. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Company (2019-2024)
Table 21. Global Long-acting Reversible Contraceptives (LARCs) Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Producing Area Distribution and Sales Area
Table 23. Players Long-acting Reversible Contraceptives (LARCs) Products Offered
Table 24. Long-acting Reversible Contraceptives (LARCs) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Long-acting Reversible Contraceptives (LARCs) Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share Geographic Region (2019-2024)
Table 29. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Long-acting Reversible Contraceptives (LARCs) Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country/Region (2019-2024)
Table 33. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Long-acting Reversible Contraceptives (LARCs) Sales by Country (2019-2024) & (K Units)
Table 36. Americas Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2019-2024)
Table 37. Americas Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2019-2024)
Table 39. Americas Long-acting Reversible Contraceptives (LARCs) Sales by Type (2019-2024) & (K Units)
Table 40. Americas Long-acting Reversible Contraceptives (LARCs) Sales by Application (2019-2024) & (K Units)
Table 41. APAC Long-acting Reversible Contraceptives (LARCs) Sales by Region (2019-2024) & (K Units)
Table 42. APAC Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2019-2024)
Table 43. APAC Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2019-2024)
Table 45. APAC Long-acting Reversible Contraceptives (LARCs) Sales by Type (2019-2024) & (K Units)
Table 46. APAC Long-acting Reversible Contraceptives (LARCs) Sales by Application (2019-2024) & (K Units)
Table 47. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2019-2024) & (K Units)
Table 48. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2019-2024)
Table 49. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2019-2024)
Table 51. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2019-2024) & (K Units)
Table 52. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Long-acting Reversible Contraceptives (LARCs)
Table 60. Key Market Challenges & Risks of Long-acting Reversible Contraceptives (LARCs)
Table 61. Key Industry Trends of Long-acting Reversible Contraceptives (LARCs)
Table 62. Long-acting Reversible Contraceptives (LARCs) Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Long-acting Reversible Contraceptives (LARCs) Distributors List
Table 65. Long-acting Reversible Contraceptives (LARCs) Customer List
Table 66. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Bayer Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 81. Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 82. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bayer Main Business
Table 84. Bayer Latest Developments
Table 85. Merck Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 86. Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 87. Merck Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Merck Main Business
Table 89. Merck Latest Developments
Table 90. Cooper Companies Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 91. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 92. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Cooper Companies Main Business
Table 94. Cooper Companies Latest Developments
Table 95. AbbVie Allergan Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 96. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 97. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. AbbVie Allergan Main Business
Table 99. AbbVie Allergan Latest Developments
Table 100. Yantai JiShengYaoXie Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 101. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 102. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Yantai JiShengYaoXie Main Business
Table 104. Yantai JiShengYaoXie Latest Developments
Table 105. H & J Medical Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 106. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 107. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. H & J Medical Main Business
Table 109. H & J Medical Latest Developments
Table 110. HRA Pharma Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 111. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 112. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. HRA Pharma Main Business
Table 114. HRA Pharma Latest Developments
Table 115. Pregna Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 116. Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 117. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Pregna Main Business
Table 119. Pregna Latest Developments
Table 120. ASPIVIX Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 121. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 122. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. ASPIVIX Main Business
Table 124. ASPIVIX Latest Developments
Table 125. Shanghai Dahua Pharmaceuticals Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 126. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 127. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Shanghai Dahua Pharmaceuticals Main Business
Table 129. Shanghai Dahua Pharmaceuticals Latest Developments
Table 130. Williams Medical Supplies Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 131. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 132. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Williams Medical Supplies Main Business
Table 134. Williams Medical Supplies Latest Developments
Table 135. Laboratoire 7 MED Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 136. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 137. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Laboratoire 7 MED Main Business
Table 139. Laboratoire 7 MED Latest Developments
Table 140. Durbin Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 141. Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 142. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Durbin Main Business
Table 144. Durbin Latest Developments
Table 145. Laboratoire CCD Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 146. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 147. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Laboratoire CCD Main Business
Table 149. Laboratoire CCD Latest Developments
Table 150. Prosan Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 151. Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 152. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Prosan Main Business
Table 154. Prosan Latest Developments
Table 155. OCON Basic Information, Long-acting Reversible Contraceptives (LARCs) Manufacturing Base, Sales Area and Its Competitors
Table 156. OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolios and Specifications
Table 157. OCON Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. OCON Main Business
Table 159. OCON Latest Developments
LIST OF FIGURES
Figure 1. Picture of Long-acting Reversible Contraceptives (LARCs)
Figure 2. Long-acting Reversible Contraceptives (LARCs) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Long-acting Reversible Contraceptives (LARCs) Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Hormonal Intrauterine Devices
Figure 10. Product Picture of Copper Intrauterine Devices
Figure 11. Product Picture of Contraceptive Implants
Figure 12. Product Picture of Others
Figure 13. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type in 2023
Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2019-2024)
Figure 15. Long-acting Reversible Contraceptives (LARCs) Consumed in Age 20-24
Figure 16. Global Long-acting Reversible Contraceptives (LARCs) Market: Age 20-24 (2019-2024) & (K Units)
Figure 17. Long-acting Reversible Contraceptives (LARCs) Consumed in Age 25-34
Figure 18. Global Long-acting Reversible Contraceptives (LARCs) Market: Age 25-34 (2019-2024) & (K Units)
Figure 19. Long-acting Reversible Contraceptives (LARCs) Consumed in Age 35-44
Figure 20. Global Long-acting Reversible Contraceptives (LARCs) Market: Age 35-44 (2019-2024) & (K Units)
Figure 21. Long-acting Reversible Contraceptives (LARCs) Consumed in Others
Figure 22. Global Long-acting Reversible Contraceptives (LARCs) Market: Others (2019-2024) & (K Units)
Figure 23. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2023)
Figure 24. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application in 2023
Figure 25. Long-acting Reversible Contraceptives (LARCs) Sales Market by Company in 2023 (K Units)
Figure 26. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Company in 2023
Figure 27. Long-acting Reversible Contraceptives (LARCs) Revenue Market by Company in 2023 ($ Million)
Figure 28. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Company in 2023
Figure 29. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Long-acting Reversible Contraceptives (LARCs) Sales 2019-2024 (K Units)
Figure 32. Americas Long-acting Reversible Contraceptives (LARCs) Revenue 2019-2024 ($ Millions)
Figure 33. APAC Long-acting Reversible Contraceptives (LARCs) Sales 2019-2024 (K Units)
Figure 34. APAC Long-acting Reversible Contraceptives (LARCs) Revenue 2019-2024 ($ Millions)
Figure 35. Europe Long-acting Reversible Contraceptives (LARCs) Sales 2019-2024 (K Units)
Figure 36. Europe Long-acting Reversible Contraceptives (LARCs) Revenue 2019-2024 ($ Millions)
Figure 37. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue 2019-2024 ($ Millions)
Figure 39. Americas Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country in 2023
Figure 40. Americas Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country in 2023
Figure 41. Americas Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2019-2024)
Figure 42. Americas Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2019-2024)
Figure 43. United States Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 44. Canada Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 45. Mexico Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 46. Brazil Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 47. APAC Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region in 2023
Figure 48. APAC Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Regions in 2023
Figure 49. APAC Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2019-2024)
Figure 50. APAC Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2019-2024)
Figure 51. China Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 52. Japan Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 53. South Korea Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 54. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 55. India Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 56. Australia Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 57. China Taiwan Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 58. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country in 2023
Figure 59. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country in 2023
Figure 60. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2019-2024)
Figure 61. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2019-2024)
Figure 62. Germany Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 63. France Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 64. UK Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 65. Italy Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 66. Russia Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 67. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country in 2023
Figure 68. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country in 2023
Figure 69. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2019-2024)
Figure 71. Egypt Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 72. South Africa Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 73. Israel Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 74. Turkey Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 75. GCC Country Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Long-acting Reversible Contraceptives (LARCs) in 2023
Figure 77. Manufacturing Process Analysis of Long-acting Reversible Contraceptives (LARCs)
Figure 78. Industry Chain Structure of Long-acting Reversible Contraceptives (LARCs)
Figure 79. Channels of Distribution
Figure 80. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Forecast by Region (2025-2030)
Figure 81. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Long-acting Reversible Contraceptives (LARCs)
Figure 2. Long-acting Reversible Contraceptives (LARCs) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Long-acting Reversible Contraceptives (LARCs) Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Hormonal Intrauterine Devices
Figure 10. Product Picture of Copper Intrauterine Devices
Figure 11. Product Picture of Contraceptive Implants
Figure 12. Product Picture of Others
Figure 13. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type in 2023
Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2019-2024)
Figure 15. Long-acting Reversible Contraceptives (LARCs) Consumed in Age 20-24
Figure 16. Global Long-acting Reversible Contraceptives (LARCs) Market: Age 20-24 (2019-2024) & (K Units)
Figure 17. Long-acting Reversible Contraceptives (LARCs) Consumed in Age 25-34
Figure 18. Global Long-acting Reversible Contraceptives (LARCs) Market: Age 25-34 (2019-2024) & (K Units)
Figure 19. Long-acting Reversible Contraceptives (LARCs) Consumed in Age 35-44
Figure 20. Global Long-acting Reversible Contraceptives (LARCs) Market: Age 35-44 (2019-2024) & (K Units)
Figure 21. Long-acting Reversible Contraceptives (LARCs) Consumed in Others
Figure 22. Global Long-acting Reversible Contraceptives (LARCs) Market: Others (2019-2024) & (K Units)
Figure 23. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2023)
Figure 24. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application in 2023
Figure 25. Long-acting Reversible Contraceptives (LARCs) Sales Market by Company in 2023 (K Units)
Figure 26. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Company in 2023
Figure 27. Long-acting Reversible Contraceptives (LARCs) Revenue Market by Company in 2023 ($ Million)
Figure 28. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Company in 2023
Figure 29. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Long-acting Reversible Contraceptives (LARCs) Sales 2019-2024 (K Units)
Figure 32. Americas Long-acting Reversible Contraceptives (LARCs) Revenue 2019-2024 ($ Millions)
Figure 33. APAC Long-acting Reversible Contraceptives (LARCs) Sales 2019-2024 (K Units)
Figure 34. APAC Long-acting Reversible Contraceptives (LARCs) Revenue 2019-2024 ($ Millions)
Figure 35. Europe Long-acting Reversible Contraceptives (LARCs) Sales 2019-2024 (K Units)
Figure 36. Europe Long-acting Reversible Contraceptives (LARCs) Revenue 2019-2024 ($ Millions)
Figure 37. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales 2019-2024 (K Units)
Figure 38. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue 2019-2024 ($ Millions)
Figure 39. Americas Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country in 2023
Figure 40. Americas Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country in 2023
Figure 41. Americas Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2019-2024)
Figure 42. Americas Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2019-2024)
Figure 43. United States Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 44. Canada Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 45. Mexico Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 46. Brazil Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 47. APAC Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region in 2023
Figure 48. APAC Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Regions in 2023
Figure 49. APAC Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2019-2024)
Figure 50. APAC Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2019-2024)
Figure 51. China Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 52. Japan Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 53. South Korea Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 54. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 55. India Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 56. Australia Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 57. China Taiwan Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 58. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country in 2023
Figure 59. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country in 2023
Figure 60. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2019-2024)
Figure 61. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2019-2024)
Figure 62. Germany Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 63. France Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 64. UK Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 65. Italy Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 66. Russia Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 67. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country in 2023
Figure 68. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country in 2023
Figure 69. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2019-2024)
Figure 71. Egypt Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 72. South Africa Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 73. Israel Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 74. Turkey Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 75. GCC Country Long-acting Reversible Contraceptives (LARCs) Revenue Growth 2019-2024 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Long-acting Reversible Contraceptives (LARCs) in 2023
Figure 77. Manufacturing Process Analysis of Long-acting Reversible Contraceptives (LARCs)
Figure 78. Industry Chain Structure of Long-acting Reversible Contraceptives (LARCs)
Figure 79. Channels of Distribution
Figure 80. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Forecast by Region (2025-2030)
Figure 81. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share Forecast by Application (2025-2030)
